Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 181 participants.
Also called NCT01208233
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 181 participants
- Sponsor
- Registry
-
NCT01208233 -
2010-021414-32
-
- Other papers using this trial's data
- Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Bulgaria, Canada, Czechia, France, Germany, Hungary, India, South Korea, Taiwan
- Registry status
- Terminated
Technical summary
Registry record NCT01208233. Randomized; quadruple masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2016-02-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- PF-03049423
- Intervention (Drug)
- PF-03049423
- Intervention (Drug)
- PF-03049423
- Intervention (Other)
- Placebo
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct01208233- Content hash
488b278a832cb47748908321dc7b73b9eff40e58439efae739317062bb3e7a72